
SCHILKE EDOARDO DALMATO
Pubblicazioni
Schilke, E., Frigo, M., Fusco, M., Cappellani, A., Cereda, D., Zoia, C., et al. (2025). Analysis of an innovative fluid biomarker panel for early prediction of progression independent of relapse activity in multiple sclerosis. MULTIPLE SCLEROSIS JOURNAL, EXPERIMENTAL, TRANSLATIONAL AND CLINICAL, 11(3), 1-13 [10.1177/20552173251372751]. Dettaglio
De Rosa, G., Russo, C., Garavelli, S., Di Silvestre, D., Spatocco, I., Mele, G., et al. (2025). MicroRNA-142-3p shuttling in extracellular vesicles marks regulatory T cell dysfunction in multiple sclerosis. SCIENCE TRANSLATIONAL MEDICINE, 17(800) [10.1126/scitranslmed.adl1698]. Dettaglio
Pupillo, E., Bianchi, E., Beghi, E., Pedrazzini, F., Giglio, A., Schilke, E., et al. (2025). Multicentre case-control study on the association between COVID-19 vaccines and neurological disorders (COVIVAX). SCIENTIFIC REPORTS, 15(1) [10.1038/s41598-025-88837-0]. Dettaglio
Schilke, E., Cereda, D., Fusco, M., Stanzani, L., Marzorati, L., Ripolone, M., et al. (2025). Eculizumab as a Disease-Modifying Therapy in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): A Case Report. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 30(1 (March 2025)) [10.1111/jns.70010]. Dettaglio
Schilke, E., Remoli, G., Cutellé, C., Balducci, C., Cereda, D., Fusco, M., et al. (2024). Corticosteroid treatment for acute hydrocephalus in neurosarcoidosis: a case report. JOURNAL OF MEDICAL CASE REPORTS, 18(1) [10.1186/s13256-024-04359-9]. Dettaglio